Regulatory

The Drug Safety Institute (DSI), a subsidiary of Brand Institute, was founded in 2004. DSI is dedicated to improving the safe use of Pharmaceuticals by providing a global, state-of-the-art, research model for proprietary (brand and line extension) and nonproprietary (USAN/INN) nomenclature research. In addition, DSI offers a medication error prevention analysis associated with labeling of pharmaceuticals, biological products and medical devices. DSI also offers various risk management strategies to our clients.

  • BRAND STRATEGY
  • USAN / INN / STEM & CLASS NAMING
  • NAME SAFETY RESEARCH
  • GAP ANALYSIS
  • REGULATORY STRATEGY
  • CONSULTS AND REBUTTALS
  • NAME SAFETY REPORTS / SUBMISSION PACKAGES
  • PRODUCT LABELING, PACKAGING & TRADE DRESS RESEARCH
  • PROMOTIONAL / ADVERTISING RESEARCH
  • FAILURE MODE AND EFFECTS ANALYSIS (FMEA)
  • REGULATORY / SAFETY REVIEW OF CONTAINER, CARTON, LABELS & PACKAGING
  • NONPROPRIETARY (USAN / INN) NAME RESEARCH
Back to top